A hallmark of cultured smooth muscle cells (SMCs) is the rapid down-regulat
ion of several lineage-restricted genes that define their in vivo different
iated phenotype. Identifying factors that maintain an SMC differentiated ph
enotype has important implications in understanding the molecular underpinn
ings governing SMC differentiation and their subversion to an altered pheno
type in various disease settings. Here, we show that several G-protein coup
led receptors [a-thrombin, lysophosphatidic acid and angiotensin II (All)]
increase the expression of smooth muscle calponin (SM-Calp) in rat and huma
n SMC. The increase in SM-Calp protein appears to be selective for G-protei
n-coupled receptors as epidermal growth factor was without effect. Studies
using AII showed a 30-fold increase in SM-Calp protein, which was dose- and
time-dependent and mediated by the angiotensin receptor-1 (AT(1) receptor)
. The increase in SM-Calp protein with AII was attributable to transcriptio
nal activation of SM-Calp based on increases in steady-state SM-Calp mRNA,
increases in SM-Calp promoter activity and complete abrogation of protein i
nduction with actinomycin D. To examine the potential role of extracellular
signal-regulated kinase (Erk1/2), protein kinase B, p38 mitogen-activated
protein kinase and protein kinase C in AII-induced SM-Calp, inhibitors to e
ach of the signalling pathways were used. None of these signalling molecule
s appears to be crucial for AII-induced SM-Calp expression, although Erk1/2
may be partially involved. These results identify SM-Calp as a target of A
ll-mediated signalling, and suggest that the SMC response to All may incorp
orate a novel activity of SM-Calp.